Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Schering-Plough Corporation
Current Parent Company: Merck
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $91,602,000
Year: 2006
Date: August 29, 2006
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: False Claims Act and related
Mega-Scandal: Improper Drug Marketing
Violation Description: Schering-Plough agreed to pay $91.6 million to settle multistate litigation alleging it engaged in illegal sales and marketing programs of its drugs Temodar and Intron A and that it engaged in Medicaid fraud irelating to its Claritin RediTabs and K-Dur products. This was part of a larger $435 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.